4.32
price up icon0.00%   0.010
 
loading
Schlusskurs vom Vortag:
$4.33
Offen:
$4.4
24-Stunden-Volumen:
445.75K
Relative Volume:
0.70
Marktkapitalisierung:
$363.76M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-5.0824
EPS:
-0.85
Netto-Cashflow:
$-57.06M
1W Leistung:
+15.78%
1M Leistung:
+31.61%
6M Leistung:
+23.36%
1J Leistung:
+125.52%
1-Tages-Spanne:
Value
$4.31
$4.525
1-Wochen-Bereich:
Value
$3.70
$4.525
52-Wochen-Spanne:
Value
$1.85
$4.91

Codexis Inc Stock (CDXS) Company Profile

Name
Firmenname
Codexis Inc
Name
Telefon
650-421-8100
Name
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
Mitarbeiter
174
Name
Twitter
@codexisinc
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
CDXS's Discussions on Twitter

Vergleichen Sie CDXS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
CDXS 4.325 363.76M 70.14M -76.24M -57.06M -0.85
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.10 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.88 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.29 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.52 24.89B 3.30B -501.07M 1.03B 11.54

Codexis Inc Stock (CDXS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-05-09 Herabstufung H.C. Wainwright Buy → Neutral
2022-03-31 Fortgesetzt Piper Sandler Overweight
2022-03-02 Fortgesetzt Cowen Outperform
2021-04-12 Eingeleitet Piper Sandler Overweight
2021-03-01 Eingeleitet Stifel Buy
2021-02-26 Bestätigt H.C. Wainwright Buy
2020-03-10 Eingeleitet The Benchmark Company Buy
2019-01-17 Hochstufung First Analysis Sec Neutral → Outperform
2018-05-16 Eingeleitet Stephens Overweight
2017-10-13 Bestätigt H.C. Wainwright Buy
2017-05-31 Eingeleitet Jefferies Buy
2017-01-26 Herabstufung First Analysis Sec Overweight → Equal-Weight
2017-01-04 Hochstufung Ladenburg Thalmann Neutral → Buy
2016-01-06 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Codexis Inc Aktie (CDXS) Neueste Nachrichten

pulisher
12:22 PM

Codexis (STU:4QK) 3-Year FCF Growth Rate : -35.00% (As of Sep. 2024) - GuruFocus.com

12:22 PM
pulisher
Nov 20, 2024

Codexis (STU:4QK) Forward Dividend Yield % : 0.00% (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Nov 20, 2024
pulisher
Nov 19, 2024

Codexis to Present at Piper Sandler Healthcare Conference in December 2024 | CDXS Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 15, 2024

Codexis (NASDAQ:CDXS) Given Overweight Rating at Cantor Fitzgerald - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Codexis Achieves 98% Efficiency in Breakthrough siRNA Synthesis Platform | CDXS Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Baillie Gifford & Co. Sells 895,002 Shares of Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Nov 14, 2024
pulisher
Nov 12, 2024

Codexis adds biotech veteran Raymond De Vré to board - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Codexis Strengthens Board and Updates Bylaws - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

CDXSCodexis, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Codexis adds biotech veteran Raymond De Vré to board By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Codexis Strengthens Board with Biotech Veteran Raymond De Vré, Former PolyPeptide CEO | CDXS Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Biofuel Enzymes Market Growth Surge: Key Players and Market - openPR

Nov 12, 2024
pulisher
Nov 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for - The Bakersfield Californian

Nov 11, 2024
pulisher
Nov 11, 2024

Codexis to Showcase Breakthrough RNA Platform, Partners with Bachem at TIDES Europe 2024 | CDXS Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 08, 2024

Codexis Announces New Employment Inducement Grants - The Manila Times

Nov 08, 2024
pulisher
Nov 07, 2024

Codexis, Inc.'s (NASDAQ:CDXS) 29% Jump Shows Its Popularity With Investors - Simply Wall St

Nov 07, 2024
pulisher
Nov 06, 2024

Benchmark Downgrades Codexis (CDXS) - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

CDXS (Codexis) PE Ratio : At Loss (As of Nov. 06, 2024) - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Codexis (FRA:4QK) 3-Year EBITDA Growth Rate : -26.40% (As of Sep. 2024) - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Benchmark Reaffirms “Hold” Rating for Codexis (NASDAQ:CDXS) - Defense World

Nov 06, 2024
pulisher
Nov 06, 2024

Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

abrdn plc Grows Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Codexis to Participate in Upcoming Healthcare Conferences - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Codexis (NASDAQ:CDXS) Earns Hold Rating from Benchmark - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17 - Yahoo Finance

Nov 03, 2024
pulisher
Nov 03, 2024

Codexis, Inc. Announces Strong Third Quarter 2024 Financial Results - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Nov 02, 2024
pulisher
Nov 02, 2024

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Codexis, Inc. (NASDAQ:CDXS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 02, 2024
pulisher
Nov 01, 2024

Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Codexis reports revenue growth and strategic focus in Q3 2024 - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Codexis Inc Q3 2024 Earnings: Revenue Hits $12.83M, Beating Esti - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ... - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Codexis Reports Strong Q3 Revenue Growth - TipRanks

Nov 01, 2024
pulisher
Oct 31, 2024

Codexis: Q3 Earnings Snapshot - CT Insider

Oct 31, 2024
pulisher
Oct 31, 2024

Codexis Reports Third Quarter 2024 Financial Results - The Manila Times

Oct 31, 2024

Finanzdaten der Codexis Inc-Aktie (CDXS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):